GeneCode is developing small-molecule drugs that bind and activate GDNF (Glial cell line-Derived Neurotrophic Factor) receptors for the treatment of Parkinson’s disease (PD) and other neurodegenerative conditions.
| Website | https://www.genecode.com |
| Revenue | $399000 |
| Employees | 4 (1 on RocketReach) |
| Founded | 1998 |
| Address | 8 Ahtri, Tallinn, Harjumaa, EE |
| Phone | +372 503 1801 |
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Pharmaceutical Development, Drug Discovery, Disease Modifying Therapies, Small Molecule Drugs, Biotechnology, Therapeutics, Pharmaceutical, Neurological Disorders, Clinical Development, Drug Development, Preclinical Development, Life Sciences, Biopharma, Research, Development, Medicine, Healthcare, Pharma |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, QIAGEN, Twist Bioscience, Oxford Nanopore Technologies, Wellcome Sanger Institute, PacBio, Bionano Genomics, Inc. +44 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Genecode employee's phone or email?
Genecode Questions
The Genecode annual revenue was $399000 in 2026.
1 people are employed at Genecode.
Genecode is based in Tallinn, Harjumaa.
The NAICS codes for Genecode are [541, 54171, 541713, 54, 5417].
The SIC codes for Genecode are [87, 873].
Top Genecode Employees
Related Companies
G2Crowd Trusted
300K+
Plugin Users
